Analyst Viewpoint
Rise in prevalence of chronic and infectious diseases and surge in demand for personalized and precision medicine are fostering the Polymerase Chain Reaction (PCR) consumables market size.
Polymerase Chain Reaction (PCR) consumables are majorly utilized in diagnosis, medication, and research processes, providing accurate and precise results. Moreover, increase in incidences of target diseases and genetic disorders is augmenting market expansion.
Technological advancements in drug development processes and increase in investments in research and development offer lucrative Polymerase Chain Reaction (PCR) consumables market opportunities to the companies operating in this industry.
Manufacturers focus on business expansion by launching new products to cater to global consumer demands. Moreover, collaborations and partnerships allow companies to enhance their brand reach in global markets.
Polymerase Chain Reaction (PCR) consumables are essential components used in the PCR process to amplify a specific segment of DNA. These consumables are designed to facilitate the PCR reaction and ensure accurate and efficient amplification.
PCR tubes or plates, PCR master mix, primers, DNA polymerase, buffer solutions, mineral oil or PCR sealing film, and PCR cleanup kits are some of the common PCR consumables. These consumables are essential to perform PCR reactions accurately and efficiently in molecular biology laboratories.
Nucleic Acid Amplification Consumables are essential components used in various nucleic acid amplification techniques, including Polymerase Chain Reaction (PCR), Reverse Transcription Polymerase Chain Reaction (RT-PCR), Loop-mediated Isothermal Amplification (LAMP), and others.
These consumables facilitate the amplification of specific nucleic acid sequences for various applications in molecular biology, diagnostics, and research. In these processes, low-retention PCR tubes for sensitive assays are employed to minimize sample loss and maximize the recovery of nucleic acids during PCR amplification.
PCR is a highly sensitive and precise technique for detecting nucleic acids, making it crucial for diagnosing infectious diseases, such as COVID-19, HIV, hepatitis, and tuberculosis. Sedentary lifestyle, poor diet, and obesity can lead to chronic diseases.
Moreover, the emergence of point-of-care PCR platforms has facilitated rapid and decentralized testing for infectious diseases, allowing for timely diagnosis and treatment. Thus, increase in prevalence of chronic and infectious diseases is contributing to the Polymerase Chain Reaction (PCR) consumables industry growth.
As per the Polymerase Chain Reaction (PCR) consumables market forecast, increase in incidences of target diseases and genetic disorders is projected to boost market progress in the near future. Chronic diseases such as cancer often require genetic screening and monitoring to guide treatment decisions and assess disease progression.
PCR-based assays, including quantitative PCR (qPCR) and digital PCR (dPCR), enable the detection of specific genetic mutations or biomarkers associated with various diseases.
According to the World Health Organization, Noncommunicable Diseases (NCDs) account for around 41 million mortalities every year, around 74% of all deaths across the globe. Cardiovascular diseases account for most NCD deaths, or 17.9 million people annually, followed by cancers (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million including kidney disease deaths caused by diabetes).
Personalized medicine relies on genetic testing to tailor medical treatment to individual patients based on their genetic makeup. Manufacturers are investing in product innovation and customization to meet evolving market needs.
This includes the development of specialized PCR reagents, low-retention PCR tubes, high-throughput PCR systems, molecular biology consumables, and multiplex PCR assays tailored to specific disease applications. Thus, surge in demand for personalized and precision medicine is augmenting the Polymerase Chain Reaction (PCR) consumables market development.
PCR reagents and supplies are widely used in biomedical research to study the genetic basis of diseases, explore disease mechanisms, and develop new therapeutic strategies. Professionals are conducting research and development activities to understand disease pathogenesis, identify drug targets, and develop vaccines.
This drives the demand for high-fidelity PCR enzyme for long templates for basic and translational research purposes. Hence, advancements in drug development are driving the Polymerase Chain Reaction (PCR) consumables market revenue.
According to the latest Polymerase Chain Reaction (PCR) consumables market insights, North America dominated the global market in 2022. Rise in prevalence of genetic and chronic diseases among the population is likely to propel the Polymerase Chain Reaction (PCR) consumables industry share during the forecast period.
Moreover, well-established healthcare infrastructure and rise in demand for precision medicine are driving the demand for Polymerase Chain Reaction (PCR) consumables, thereby fueling market statistics.
According to data from the American Cancer Society, in 2022, around 1.9 million new cancer cases were diagnosed and 609,360 cancer fatalities were estimated in the United States. Healthcare professionals are working on providing effective treatments for these diseases using precision medicine.
As per the recent Polymerase Chain Reaction (PCR) consumables market trends, advancements in drug development and disease diagnosis technologies offer lucrative opportunities to the companies operating in this sector. Leading players in the market are launching new products and forming collaborations to improve their business performance by diversifying their product portfolio.
Some of the players in the industry are Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Agilent Technologies, Inc., Eppendorf SE, 4titude Ltd., Corning Incorporated, and Greiner Bio-One International GmbH.
These companies have been profiled in the Polymerase Chain Reaction (PCR) consumables market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.
Attribute | Detail |
---|---|
Market Size in 2022 | US$ 520.5 Mn |
Market Forecast (Value) in 2031 | US$ 754.4 Mn |
Growth Rate (CAGR) | 4.3% |
Forecast Period | 2023-2031 |
Historical Data Available for | 2017-2021 |
Quantitative Tons | US$ Mn for Value |
Market Analysis | It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format | Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope | Available upon request |
Pricing | Available upon request |
It was valued at US$ 520.5 Mn in 2022
It is projected to register a CAGR of 4.3% from 2023 to 2031
Rise in prevalence of chronic and infectious diseases and surge in demand for personalized and precision medicine
North America was the most lucrative region in 2022
Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., QIAGEN, Merck KGaA, Agilent Technologies, Inc., Eppendorf SE, 4titude Ltd., Corning Incorporated, and Greiner Bio-One International GmbH
1. Executive Summary
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Polymerase Chain Reaction (PCR) Consumables Market
4. Market Overview
4.1. Market Segmentation
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Polymerase Chain Reaction (PCR) Consumables Market Analysis and Forecasts, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
5.3. COVID-19 Pandemic Impact on Industry
6. Polymerase Chain Reaction (PCR) Consumables Market Analysis and Forecast, by Product
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. PCR Tubes
6.3.2. PCR Microplates
6.3.3. Caps/Lids
6.3.4. Others
6.4. Market Attractiveness, by Product
7. Global Polymerase Chain Reaction (PCR) Consumables Market Analysis and Forecast, by End-user
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Research and Academic Institutes
7.3.2. Clinical Diagnostic Labs and Hospitals
7.3.3. Pharmaceutical and Biotechnology Companies
7.3.4. Others
7.4. Market Attractiveness, by End-user
8. Global Polymerase Chain Reaction (PCR) Consumables Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region, 2017–2031
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness, by Region
9. North America Polymerase Chain Reaction (PCR) Consumables Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product, 2017–2031
9.2.1. PCR Tubes
9.2.2. PCR Microplates
9.2.3. Caps/Lids
9.2.4. Others
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Research and Academic Institutes
9.3.2. Clinical Diagnostic Labs and Hospitals
9.3.3. Pharmaceutical and Biotechnology Companies
9.3.4. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Polymerase Chain Reaction (PCR) Consumables Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. PCR Tubes
10.2.2. PCR Microplates
10.2.3. Caps/Lids
10.2.4. Others
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Research and Academic Institutes
10.3.2. Clinical Diagnostic Labs and Hospitals
10.3.3. Pharmaceutical and Biotechnology Companies
10.3.4. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. PCR Tubes
11.2.2. PCR Microplates
11.2.3. Caps/Lids
11.2.4. Others
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Research and Academic Institutes
11.3.2. Clinical Diagnostic Labs and Hospitals
11.3.3. Pharmaceutical and Biotechnology Companies
11.3.4. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Polymerase Chain Reaction (PCR) Consumables Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. PCR Tubes
12.2.2. PCR Microplates
12.2.3. Caps/Lids
12.2.4. Others
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Research and Academic Institutes
12.3.2. Clinical Diagnostic Labs and Hospitals
12.3.3. Pharmaceutical and Biotechnology Companies
12.3.4. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. PCR Tubes
13.2.2. PCR Microplates
13.2.3. Caps/Lids
13.2.4. Others
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Research and Academic Institutes
13.3.2. Clinical Diagnostic Labs and Hospitals
13.3.3. Pharmaceutical and Biotechnology Companies
13.3.4. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of Companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Bio-Rad Laboratories, Inc.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. F. Hoffmann-La Roche Ltd.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Thermo Fisher Scientific Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. QIAGEN.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Merck KGaA
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Agilent Technologies, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Eppendorf SE
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. 4titude Ltd.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Corning Incorporated
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Greiner Bio-One International GmbH
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
List of Tables
Table 1: Global Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 2: Global Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 3: Global Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 4: North America Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 5: North America Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 6: North America Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 7: Europe Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 8: Europe Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 9: Europe Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by End-user 2017–2031
Table 10: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 11: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 12: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Latin America Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Latin America Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 15: Latin America Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by End-user 2017–2031
Table 16: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 18: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, by End-user 2017–2031
List of Figures
Figure 1: Global Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, 2017–2031
Figure 2: Global Polymerase Chain Reaction (PCR) Consumables Market Value Share, by Product, 2022
Figure 3: Global Polymerase Chain Reaction (PCR) Consumables Market Value Share, by End-user, 2022
Figure 4: Global Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Product, 2022–2031
Figure 5: Global Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Product, 2023–2031
Figure 6: Global Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by End-user, 2022–2031
Figure 7: Global Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by End-user, 2023–2031
Figure 8: Global Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Region, 2022–2031
Figure 9: Global Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Region, 2023–2031
Figure 10: North America Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, 2017–2031
Figure 11: North America Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Country, 2022–2031
Figure 12: North America Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Country, 2023–2031
Figure 13: North America Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Product, 2022–2031
Figure 14: North America Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Product, 2023–2031
Figure 15: North America Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by End-user, 2022–2031
Figure 16: North America Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by End-user, 2023–2031
Figure 17: Europe Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, 2017–2031
Figure 18: Europe Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 19: Europe Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 20: Europe Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Product, 2022–2031
Figure 21: Europe Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Product, 2023–2031
Figure 22: Europe Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by End-user, 2022–2031
Figure 23: Europe Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by End-user, 2023–2031
Figure 24: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, 2017–2031
Figure 25: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 26: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 27: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Product, 2022–2031
Figure 28: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Product, 2023–2031
Figure 29: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by End-user, 2022–2031
Figure 30: Asia Pacific Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by End-user 2023–2031
Figure 31: Latin America Polymerase Chain Reaction (PCR) Consumables Market Value (US$ Mn) Forecast, 2017–2031
Figure 32: Latin America Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 33: Latin America Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 34: Latin America Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Product, 2022–2031
Figure 35: Latin America Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Product, 2023–2031
Figure 36: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 37: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by Product, 2022–2031
Figure 39: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by Product, 2023–2031
Figure 40: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Value Share Analysis, by End-user, 2022–2031
Figure 41: Middle East & Africa Polymerase Chain Reaction (PCR) Consumables Market Attractiveness Analysis, by End-user 2023–2031
Figure 42: Global Polymerase Chain Reaction (PCR) Consumables Market Share Analysis, by Company (2022)